Stockreport

IMV Inc. Announces Third Quarter 2019 Financial Results and Provides Corporate Update

IMV Inc. - Common Shares  (IMV) 
PDF Reported preliminary data from Phase 2 basket study of DPX-Survivac in multiple solid tumors at the ESMO annual meeting, showing treatment was well-tolerated and showed [Read more]